Invokana is an oral SGLT2 inhibitor medication used to treat type 2 diabetes. It was first released in 2013 and is now quite popular amongst doctors as well as consumers. Unfortunately, people are claiming that they have experienced some serious health conditions while taking Invokana (canagliflozin). Here, we’ll list some important Invokana facts, including FDA warnings as well as potentially deadly diabetic ketoacidosis, stroke, kidney failure and amputation risks. Of course, it’s entirely up to patients to decide whether Invokana dangers may outweigh the drug’s benefits.
5 Important Invokana Facts
1. Invokana Facts: Invokana Lowers Blood Sugar In Type 2 Diabetics
The U.S. Food and Drug Administration approved Invokana in 2013 in order to treat Type 2 diabetes. The medication is classified as a sodium-glucose cotransporter-2 (SGLT2) inhibitor drug which effectively works by helping the kidneys eliminate glucose through urine.
2. Invokana Facts: Generically Known As Canagliflozin
Invokana’s generic name is canagliflozin. As a result, this is the drug name researchers often use instead of Invokana.
3. Invokana Facts: There Are Many Nearly Identical SGLT2 Inhibitors Available
There are several other SGLT2 inhibitors on the market similar to Invokana. Additionally, other canagliflozin formulations are sold under the brand names Invokamet, Farxiga, Xigduo XR, Jardiance, and Glyxambi.
4. Invokana Facts: It Can Cause Potentially Deadly Side Effects
The FDA released a drug safety communication about Invokana in May 2015. This warning came after multiple adverse event reports linked Invokana and diabetic ketoacidosis. Ketoacidosis is a serious condition that can cause high levels of acid to form within the blood and potentially lead to coma or death.
5. Invokana Facts: Taking SGLT2 Inhibitors Nearly Doubles The Risk For Leg, Foot and Toe Amputations
In May 2016, the FDA updated Invokana’s black box warning label to mention increased amputation risks. According to data from two large clinical studies, type 2 diabetes patients taking Invokana as well as Invokamet showed nearly 2x the risk for lower limb amputations compared with non-users.
What You Can Do
Attorneys are now accepting claims from patients suffering leg, toe and foot amputations while taking Invokana. If you were diagnosed with ketoacidosis while taking canagliflozin, you may have an eligible Invokana lawsuit claim. To learn how to get the justice and compensation you deserve, fill out your free claim evaluation today.